Document the screening result and the clinical decision (approve, defer, or refuse treatment) in the patient record
Bendahan D, Mattei JP, Ghattas B, Confort-Gouny S, Le Guern ME, Cozzone PJ
Results GLP-1RA reduced major cardiovascular events (MACE) by 14% (HR = 0.86, 95% CI 0.790.94, P = 0.006) with a non-significant heterogeneity between subgroups of patients with and without cardiovascular disease (P = 0.127)
The Benefits of Vitamin C IV Therapy Tapping into the actual benefits of high dose intravenous vitamin C, research has shown a notable effect on relieving chemotherapy-related side effects as well as the overall improved quality of life in cancer patients
This syringe includes a passive needle retraction feature that eliminates the need to recap, reducing exposure and further lowering contamination risks